                         SEQUENCE LISTING

<110>  THE CLEVELAND CLINIC FOUNDATION
 
<120>  AFFINITY PROBES FOR DEFINING PROTEIN-LIPID CONTACTS

<130>  CCF-34623/WO-1/ORD

<150>  US 62/246,297
<151>  2015-10-26

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  1

Ala Lys Leu Thr Ala Leu Thr Leu Leu Gly Leu Gly Leu Ala Leu Phe 
1               5                   10                  15      


Asp Gly Gln Lys 
            20  


<210>  2
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  2

Ile Phe Tyr Tyr Asp Pro Lys 
1               5           


<210>  3
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  3

Ala Thr Asn Asp His Tyr Phe Ala Asp Pro Tyr 
1               5                   10      


<210>  4
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  4

Ala Lys Leu Thr Ala Leu Thr Glu Leu Gly Leu Gly Leu Ala Leu Phe 
1               5                   10                  15      


Asp Gly Gln Lys 
            20  


<210>  5
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  5

Ile Phe Glu Tyr Asp Pro Lys 
1               5           


<210>  6
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  6

Ala Thr Asn Asp His Glu Phe Ala Asp Pro Tyr 
1               5                   10      


<210>  7
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  7

Ala Lys Leu Thr Ala Leu Thr Lys Leu Gly Leu Gly Leu Ala Leu Phe 
1               5                   10                  15      


Asp Gly Gln Lys 
            20  


<210>  8
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  8

Ile Phe Lys Tyr Asp Pro Lys 
1               5           


<210>  9
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  9

Ala Thr Asn Asp His Lys Phe Ala Asp Pro Tyr 
1               5                   10      


<210>  10
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide

<400>  10

Thr His Leu Ala Pro Tyr Ser Asp Glu Leu Arg 
1               5                   10      


